Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways

Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways have?

Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways has 54 citations in the OpenAlex counts ScholarIQ stores.

When was Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways published?

Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways has 2022 year in the ScholarIQ index.

What is the open-access status of Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways?

Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways has gold oa status in the ScholarIQ index.

What is the DOI of Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways?

The DOI for Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways is on the source record.

What is the PMID of Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways?

The PMID for Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways is on the source record.

What is the OpenAlex record for Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways?

The OpenAlex for Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways is on the source record.